Paul A. S. Fishkin

Prospective International Randomized Phase II Study of Low-Dose Abiraterone With Food Versus Standard Dose Abiraterone In Castration-Resistant Prostate Cancer

Russell Z. Szmulewitz, Cody J. Peer, Abiola Ibraheem et al. · Journal of Clinical Oncology · 2018 · 177 citations · Full text

Urology, Purpose Abiraterone Acetate, Medicine +12

Tetracycline to prevent epidermal growth factor receptor inhibitor‐induced skin rashes

Aminah Jatoi, Kendrith M. Rowland, Jeff A. Sloan et al. · Cancer · 2008 · 172 citations · Full text

Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling

Alexa B. Schrock, Shuyu Dan Li, Garrett M. Frampton et al. · Journal of Thoracic Oncology · 2017 · 164 citations · Full text

Somatic Variant, Tumor Heterogeneity, Comprehensive Genomic Profiling +9

Fulvestrant in Women With Advanced Breast Cancer After Progression on Prior Aromatase Inhibitor Therapy: North Central Cancer Treatment Group Trial N0032

James N. Ingle, Vera J. Suman, Kendrith M. Rowland et al. · Journal of Clinical Oncology · 2006 · 151 citations · Full text

Phase II trial of dolastatin-10 in patients with advanced breast cancer

Edith A. Perez, David W. Hillman, Paul A. S. Fishkin et al. · Investigational New Drugs · 2005 · 99 citations

Advanced Breast Cancer, Breast Oncology, Oncology +7